CBG Demonstrates Potential to Treat Rheumatoid Arthritis — Anti‑inflammatory Capacity Confirmed (New Study)
A new study found that the hemp-derived compound cannabigerol (CBG) exhibits anti-inflammatory properties and neutrophil-mediated immune‑modulatory therapeutic potential in rheumatoid arthritis. CBG exerted regulatory effects that limit the infiltration of inflammatory immune cells into joints, highlighting it as a next‑generation therapeutic candidate following CBD.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
marijuanamoment.net
This content is a summary and editorial by CannabisInsight based on the above source. Copyright of the original article belongs to the respective publisher.
Original Link
https://www.marijuanamoment.net/the-cannabis-component-cbg-shows-promise-in-treating-rheumatoid-arthritis-with-its-anti-inflammatory-capacity-study-finds/